Patent Reform Draft Would Ease Problem of Subject Matter Eligibility
April 23, 2019
By: Mark McCarty
BioWorld MedTech
Axinn counsel Thomas Hedemann was quoted in the BioWorld MedTech article, "Patent Reform Draft Would Ease Problem of Subject Matter Eligibility."
Click here to access the article. A subscription is required.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
ABA White Collar Crime Institute 2026
Speaking Engagement
Consumer Brands CPG Legal Forum 2026
Speaking Engagement
NBA CLS 39th Annual Corporate Counsel Conference
Sponsorship
Antitrust
New Frontiers of Antitrust – 16th Annual International Conference of Concurrences Review
Speaking Engagement
Antitrust
GCR Live Global: Navigating the Future of Antitrust 2026
Speaking Engagement
Antitrust
Healthcare Antitrust Year-In-Review Webinar
Webinar
Antitrust
Axinn Antitrust Insight: FTC Announces Revised HSR Thresholds for 2026
Axinn Viewpoints
Antitrust
Axinn Announces Nominations for the Concurrences 2026 Antitrust Writing Awards
Awards & Recognitions
Antitrust
SABA North America Corporate Counsel Retreat 2026
Speaking Engagement
Antitrust
Axinn Promotes Lindsey Strang Aberg, Rebecca L. Clegg, Allison Vissichelli, and Eva Yung to Partner; Ricardo Camposanto, Danielle D. Irvine, and Josh Jowdy to Counsel
News
Antitrust
